Recent Developments
|
August 2018 Novel, potent and selective payloads with new modes of action and anchor groups with click chemistry Useable as payloads e.g. in Antibody-Drug-Conjugates |
|
|
||
|
|
|
August 2018 New analytical Standards: Microcystin-LY and Anatoxin-a |
|
|
||
|
|
New Collaborations
          |
|
September 2019 Cyano Biotech collaborates with Bayer Bayer and Cyano Biotech collaborate in the field of whole-cell biotransformation towards the production of chemical intermediates. |
|
||
|
|
          |
|
June 2019 Cyano Biotech collaborates with BASF BASF and Cyano Biotech collaborate to discover novel pesticides from natural sources. |
|
||
|
|
          |
|
June 2019 Cyano Biotech collaborates with Glycotope Cyano Biotech and Glycotope started a collaboration for testing Glycotope's antibody technology and Cyano Biotech's novel payloads towards the development of ADCs for targeted cancer therapies. |
|
||
|
|
          |
|
May 2019 Cyano Biotech collaborates with Heidelberg Pharma Research Cyano Biotech GmbH and Heidelberg Pharma Research GmbH collaborate regarding the development of Microcystin-based ADCs. |
|
||
|
|
Recent Publications and Patents
|
November 2018 and January 2019 We have applied for two patents protecting our IP on microcystins as payloads for ADCs and how to generate non-ribosomal peptides with “clickable” features. |
|
|
||
|
|
|
March 2017 Systems analysis of ethanol production in the genetically engineered cyanobacterium Synechococcus sp. PCC 7002 Paper published in Biotechnology for Biofuels |
|
|
||
|
|
Running Projects
|
October 2016 - ongoing CyFi CyFi - Screening for and development of novel age-modulating compounds from cyanobacteria including prediction of affected targets - granted by Investitionsbank Berlin within the framework of ProFIT. This project is co-funded by the European Regional Development Fund (EFRE).
|
|
|
||
|
|